PTI | Beijing | Updated: 29-06-2021 12:31 IST | Created: 29-06-2021 12:03 IST
Representative Image Image Credit: ANI
Country:
SHARE
Two doses of the China-made COVID-19 vaccine, CoronaVac, are safe and produce a strong antibody response among children and adolescents aged 3-17 years, according to a study published in The Lancet Infectious Diseases journal.
The phase 1/2 trial on 550 young people found that over 96 per cent of children and adolescents who received two doses of the vaccine, manufactured by Sinovac, developed antibodies against SARS-CoV-2, the virus that causes COVID-19.
Advertisement
Most adverse reactions were mild or moderate, with pain at the injection site the most commonly reported symptom, the researchers said.
China
Zanhuang
Hebei
Japan
South-korea
Han
Qiang-gao
Sinovac-life-sciences
Lancet-infectious-diseases
Zanhuang-county
Professor-bin-cao
China-japan-friendship-hospital